Effectiveness of Chitosan and Its Nanoparticles Against ampC- and ESBL-Producing Pan-Drug-Resistantin Egyptian Livestock.

Abstract

() serves as a multi-host-pathogen regarded as an alarming foodborne infectious disease, causing illnesses of variable severity in both livestock and human beings. The present study aimed to estimate the prevalence, antibiotic susceptibility profiles, and associated antimicrobial resistance genes (ARGs) ofisolates obtained from diseased broiler chickens and native Egyptian buffaloes in Kafr El-Sheikh and Dakahlia governorates, Egypt. In addition, this study investigated the antibacterial activity of chitosan (CS) and chitosan nanoparticles (CSNPs), including the estimation of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CS at concentrations of 1% and 2%, as well as CSNPs. Furthermore, the sub-MIC values were utilized to assess the inhibitory effects of CS and CSNPs on swarming motility.was detected in 68% (34/50) of broiler chickens and 40.74% (11/27) of buffaloes. Interestingly, allisolates were tested against 21 antimicrobial drugs and showed high resistance against either critical, highly important, or important antimicrobial drugs. For chicken-originated, 50% (17/34) of isolates were revealed to be extensively drug-resistant (XDR) and 50% (17/34) of isolates were revealed to be pan-drug-resistant (PDR). Meanwhile, 9.09% (1/11) of buffalo-originatedisolates were revealed to be XDR and 90.91% (10/11) of the isolates were revealed to be PDR. Amongisolates from broiler chickens, the prevalence of resistance genes was as follows:1 (97.06%),A1 (100%),2 (97.06%),A1 (44.12%),A1 (97.06%),(M) (81.82%),B (23.53%),A (0%),A (47.06%),S (0%),A (0%),1 (11.76%),(97.06%),(26.47%),(2.94%),(41.18%), and(0%). The corresponding detection rates in buffalo-derived isolates were 100%, 100%, 90.91%, 63.64%, 100%, 70.59%, 18.18%, 0%, 9.09%, 0%, 0%, 18.18%, 81.82%, 18.18%, 18.18%, 63.64%, and 0%, respectively. Carbapenemase genes were found in none of the isolates from either species. CSNPs demonstrated superior antibacterial and anti-virulence activity against resistant. CSNPs exhibited significantly lower MIC (0.067-0.081 mg/mL) and MBC (0.167-0.177 mg/mL) values compared with conventional CS formulations (MIC: 3.25-4.5 mg/mL; MBC: 6.67-9.08 mg/mL) in both broiler and buffalo isolates. In inhibition zone assays, the CSNPs + ciprofloxacin (CIP) combination showed the highest efficacy with a 50-58% increase in the inhibition area. Both CSNPs and CS 2% substantially reduced swarming motility by 45-52%, with CSNPs showing the strongest inhibitory effect. These outcomes highlight howcarries and disseminates antibiotic resistance, presenting serious threats to health policy and livestock. Also, CS or CSNPs, either alone or enhanced with CIP, are effective in vitro against resistant, which promotes the treatment ofinfections to guarantee a bactericidal impact.